We are live on ! Find out more
OGEN icon

Oragenics

18 hedge funds and large institutions have $86K invested in Oragenics in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 2

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

38% more funds holding

Funds holding: 1318 (+5)

38% more capital invested

Capital invested by funds: $62.2K → $86K (+$23.7K)

0% less ownership

Funds ownership: 0.06%0.06% (-0%)

Holders
18
Holders Change
+5
Holders Change %
+38.46%
% of All Funds
0.24%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
3
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change

OGEN Hedge Fund Activity: Q4 2024 in Review

18 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q4 2024, worth a combined $86K — up 38% from $62.2K a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new OGEN positions and 2 closed out — a net gain of 5 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was XTX Topco, opening a new position worth an estimated $13.3K. The largest seller was Virtu Financial, exiting entirely with an estimated $8K sold.

  • 18 institutional investors held Oragenics (OGEN) as of Q4 2024, up from 13 in Q3 2024.
  • Funds reported $86K of Oragenics stock for Q4 2024, up 38% quarter-over-quarter.
  • 7 funds opened new Oragenics positions in Q4 2024 and 2 closed out, a net change of +5 holders.
  • The largest Oragenics buyer in Q4 2024 was XTX Topco, an estimated $13.3K added.
  • The largest Oragenics seller in Q4 2024 was Virtu Financial, an estimated $8K sold.

Based on aggregated 13F filings for Q4 2024.